In this distressed times, we are doing our level best to keep laboratory functions in time but logistics is not in our control. Due to COVID and related lockdowns, there would be challenges in logistics and we regret for the inconvenience if any due to this.

Mission

Being in the healthcare industry, it is the patient who is both our primary customer and concern. Ensuring that the right value is given in right time to the right patient is the test we undergo everyday successfully.

Vision

Thyrocare should serve to 50% of world's population, 50% of their diagnostic needs, at 50% of the costs. Thyrocare should be the biggest client for top 20 diagnostic manufacturing companies in the globe.


Management

management image
Dr. A. Velumani, Promoter, Chairman, Managing Director

He is a BSc in Chemistry from the University of Madras and has an MSc in Biochemistry  from the University of Bombay and a PhD in Thyroid Physiology from the University of Bombay. He has over 35 years of experience in  diagnostics Research and Business. After 15 years of experience in Thyroid Biochemisry Research  at the Bhabha Atomic Research Centre – BARC Mumbai He started Thyrocare in 1995. Using a unique business model in a focused Biochemistry back end laboratory, he has built an organization which got listed in National Stock Exchange in May 2017, with a stellar oversubscription of 74 times. He is also MD of Nueclear Healthcare Limited, which is a Radiology vertical, that focuses on Cyclotrons and PETCT for diagnosing and monitoring in Oncology.

management image
Mr. A. Sundararaju, Executive Director and Chief Financial Officer

He is a graduate in law from the University of Bombay. He has over 18 years of experience in finance, legal and administrative activities. He has been in charge of the finance, legal, administrative and franchisee departments of our Company since 1996. He has been a Director on our Board since incorporation.